EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

InvestmentUpdated on 25 September 2026

Strategic Investment and Partnership Opportunities with Luxna Biotech

About

Luxna Biotech is an Osaka University spinout developing antisense oligonucleotide (ASO) therapeutics using its proprietary nucleic acid chemistry and LuxiAP™ drug discovery platform. We have experience collaborating with pharmaceutical and chemical companies and are advancing our own pipeline, including a neuroprotective treatment for glaucoma and a mutation independent treatment for DMD.

We are seeking strategic investment and business partnerships that combine capital with development expertise, research capabilities, or commercial reach. We welcome discussions with pharmaceutical companies, biotechnology companies, strategic investors, and venture capital firms interested in joint development, platform collaboration, or broader strategic transactions.